- Total Pro Portfolios with IMCL:
- Barrons 13D filings - Activist Stocks 9/25
- BAM Capital
- show more
- Total Do-It-Yourself Portfolios with IMCL:
- My Stock portfolio
- Mike
- sam s Portfolio 1
- thomas hulse Portfolio 1
- Bravo Portfolio 1
- Loveraft
- SoftWhere Portfolio 1
- artcash
- Woodrow Portfolio 1
- bry1
- brunoseiler Portfolio 1
- Diversified Growth and Short Term Gain
- Mid Cap growth
- lady Portfolio 1
- chance 1
- gurdev1singh Portfolio 1
- prve
- Mr. Science's Healthy Choices
- SUPRATRADE-QUANTUM 19
- imcl
- sdmay Portfolio 1
- INJAH
- jimmeadors Portfolio 1
- jz17 Portfolio 1
- eusebioa Portfolio 1
- fi nesh Portfolio 1
- don698 Portfolio 1
- rpcorn Portfolio 1
- GG Biotech Watch
- teeky123
- SUPRATRADE FLASH
- Brookside Capital Partners
- Nicholas A Coffey Watchlist 1
- SUPRATRADE 3007071748
- TD AmeritradeSP
- MyList_Girish
- Barron's Insider Purchases 9-15-2007
- chiutse
- Terrible T's
- amarmaharaj Portfolio 1
- Betsi Siddall Portfolio 1
- FALCNGNZX2_A
- aweismanIRA
- meligon Portfolio 1
- triballeg Portfolio 1
- Fast Money's ASCO Biotech Trades
- Fast Money's Biotech Trades & Options Action
- RAPTOR SPRTD-0710080827
- show more
- 96
- JKL Moneymaker
- M Raley Portfolio 1
- R 2007
- kl Portfolio 1
- Jackson Noel Portfolio 1
- SAMMYSARFATY Portfolio 1
- adowns Portfolio 1
- shang Portfolio 1
- My Holdings = Total Nonsense
- Sesom Portfolio 1
- wvanalle Portfolio 1
- Items I Own
- hwalk Portfolio 1
- The Black Hole
- SUPRATRADE-OMEGA 18
- JAMES PICKS
- TomKennedy Portfolio 1
- rajs pick
- dad Portfolio 1
- r burritt Portfolio 1
- rpulik Portfolio 1
- Roberto Seidner Portfolio 1
- RBlatman Portfolio 1
- April 16
- tomandprisha Portfolio 1
- C070707
- nonionfolio
- giovazza Portfolio 1
- jrkl88 Portfolio 1
- RAPTOR XI
- stewarg66slimlistII
- ehKee Portfolio 1
- teg Portfolio 3
- eddoc2k Portfolio 1
- molly
- SUPRATRADE " BUY IT ALL TODAY" ( 12.september)
- Insider Purchases and Buybacks XXII
- Stockwatch I
- JA_071002
- possible_stocks
- C2B
- msbeatty Portfolio 1
- wallstcharley Portfolio 1
- PART 3 JPMorgan 26th Annual Healthcare Conf 1/8/08..2nd Day Reporting Companies..Nymph Take
- ASCO is coming...Papers released May 15
- Fast Money's Whale Trades
- RAPTOR 230 SPRTD
- Barron's Interview Carl Icahn
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:11 29 08 |
Icahn's recent winners include Time Warner (TWX); ImClone, which Eli Lilly (LLY) bought recently; and the Stratosphere, a Las Vegas hotel and casino that Icahn sold at a big premium. His effort to get board representation on Biogen (BIIB) came up short, however. And the jury is still out on Yahoo! (YHOO) and Motorola (MOT), in which he has large stakes and board representation. |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:08 06 08 |
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
3 Stocks I Saw on TV: |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:07 30 08 |
As of March 31st the following were Carl Icahn’s top 5 holdings; Biogen (BIIB), Blockbuster (BBI), Imclone (IMCL), Motorola (MOT) and Yahoo! (YHOO). This hasn’t been the best Carl year, observes Karen Finerman. Sometimes the most talented doctors have patients who die, adds Jeff Macke. |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:05 29 08 |
We’re talking about lung cancer, explains CNBC Pharmaceuticals Reporter Mike Huckman. Look for headline-grabbing test results out of ImClone (IMCL). |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Imclone (IMCL) was downgraded from Equal-weight to Underweight, Morgan Stanley said. $38 price target. Do not expect ASCO data to meet expectations. Erbitux sales estimates also cut. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Imclone (IMCL) was upgraded to Buy, Citigroup said. $52 price target. Expect the company to post positive FLEX data at the upcoming ASCO conference. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Imclone Systems (IMCL) was upgraded to Outperform, Cowen said. Company has yet to receive full credit for FLEX trial. Risk-reward is attractive, given the commercial viability of Erbitux for lung cancer. |
|
Not yet rated
Rate now:
|
|
By:TMG |
Date:09 30 07 |
Favorite bio-tech. |
|
Not yet rated
Rate now:
|
|
By:sarah z |
Date:09 19 07 |
Finally, we have ImClone Systems making the list. This biotech's CEO, John H. Johnson, recently purchased 13,609 shares worth half a million dollars. Just days later, the stock rocketed 18% following positive news about ImClone's cancer drug Erbitux. Johnson says it was just "pure confidence." |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:warrenyost |
Date:01 18 07 |
suspected lack of ethics |
|
Not yet rated
Rate now:
|
|
Date:12 08 06 |
|
Icahn is nervous |
|
Not yet rated
Rate now:
|
|








